These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2676339)

  • 1. A critique of recent research on the two-treatment crossover design.
    Fleiss JL
    Control Clin Trials; 1989 Sep; 10(3):237-43. PubMed ID: 2676339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The crossover experiment for clinical trials.
    Brown BW
    Biometrics; 1980 Mar; 36(1):69-79. PubMed ID: 7370374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the crossover design in the presence of residual effects.
    Lehmacher W
    Stat Med; 1991 Jun; 10(6):891-9. PubMed ID: 1876779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal and efficient crossover designs under different assumptions about the carryover effects.
    Hedayat AS; Stufken J
    J Biopharm Stat; 2003 Aug; 13(3):519-28. PubMed ID: 12921398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-period crossover designs for two treatments.
    Ebbutt AF
    Biometrics; 1984 Mar; 40(1):219-24. PubMed ID: 6733230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Bayesian analysis of the two-period crossover design for clinical trials.
    Grieve AP
    Biometrics; 1985 Dec; 41(4):979-90. PubMed ID: 3830262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal crossover designs in the presence of carryover effects.
    Laska E; Meisner M; Kushner HB
    Biometrics; 1983 Dec; 39(4):1087-91. PubMed ID: 6671121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple method for the estimation of interaction bias in crossover studies.
    Cleophas TJ
    J Clin Pharmacol; 1990 Nov; 30(11):1036-40. PubMed ID: 2243151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal and/or Efficient Two treatment Crossover Designs for Five Carryover Models.
    Gondaliya J; Divecha J
    Int J Biostat; 2018 Nov; 14(2):. PubMed ID: 30471221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The performance of the two-stage analysis of two-treatment, two-period crossover trials.
    Freeman PR
    Stat Med; 1989 Dec; 8(12):1421-32. PubMed ID: 2616932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crossover trials with a binary response: a powerful method despite the carryover effect.
    Cleophas TJ; van Lier HJ
    J Clin Pharmacol; 1996 Mar; 36(3):198-202. PubMed ID: 8690812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carryover bias in clinical investigations.
    Cleophas TJ
    J Clin Pharmacol; 1993 Sep; 33(9):799-804. PubMed ID: 8227475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crossover trials comparing several treatments.
    Newcombe RG
    J Clin Periodontol; 1992 Nov; 19(10):785-7. PubMed ID: 1452805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using baseline measurements in the two-period crossover clinical trial.
    Willan AR; Pater JL
    Control Clin Trials; 1986 Dec; 7(4):282-9. PubMed ID: 3802851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-period crossover trials.
    Matthews JN
    Stat Methods Med Res; 1994 Dec; 3(4):383-405. PubMed ID: 7889228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carryover negligibility and relevance in bioequivalence studies.
    Ocaña J; Sanchez O MP; Carrasco JL
    Pharm Stat; 2015; 14(5):400-8. PubMed ID: 26175204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and analysis issues for crossover designs in phase I clinical studies.
    Boon PC; Roes KC
    J Biopharm Stat; 1999 Mar; 9(1):109-28. PubMed ID: 10091913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Handling of baseline measurements in the analysis of crossover trials.
    Chen X; Meng Z; Zhang J
    Stat Med; 2012 Jul; 31(17):1791-803. PubMed ID: 22715129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the proper use of the crossover design in clinical trials: part 18 of a series on evaluation of scientific publications.
    Wellek S; Blettner M
    Dtsch Arztebl Int; 2012 Apr; 109(15):276-81. PubMed ID: 22567063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The two-period crossover design in medical research.
    Woods JR; Williams JG; Tavel M
    Ann Intern Med; 1989 Apr; 110(7):560-6. PubMed ID: 2923388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.